CNS Oncology (CNSO)

CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analyzed by international experts, and the importance of the most recent advances in molecular biology are explained. High-quality, methodologically sound papers are considered in the following areas: Diagnosis and imaging Staging Epidemiology Case reports/case series Patient perspectives Pharmacoeconomics and outcomes research Pathology Palliative Care Radiotherapy Chemotherapy Surgical approaches Systemic therapies Adjuvant therapy Biomarkers Clinical trials – protocols and updates Comparative effectiveness Molecular biology of disease Molecular diagnostics Risk and prevention

CNS Oncology (CNSO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Risk and prevention, Molecular diagnostics, Molecular biology of disease, Biomarkers, Chemotherapy, Surgical approaches, Adjuvant therapy , Online or Print , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2045-0907, E-ISSN: 2045-0915, Established: 2012, Impact Factor: 3.8
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE